Sunita Shankar

12PUBLICATIONS
86CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 20, 2025
SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53-KRAS Oncogenic Synergy.

Paramita Ray, Shirish Shukla, Yaqing Zhang

|Aug 29, 2023
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.

Reyaz Ur Rasool, Caitlin M O'Connor, Chandan Kanta Das

|Aug 04, 2022
Argonaute 2 modulates EGFR-RAS signaling to promote mutant HRAS and NRAS-driven malignancies.

Ronald F Siebenaler, Seema Chugh, Jessica J Waninger

|Apr 09, 2022
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue.

Job van Riet, Chinmoy Saha, Nikolaos Strepis

|Nov 19, 2021
G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer.

Chandrani Mukhopadhyay, Chenyi Yang, Limei Xu

Pageof 2